Reuters logo
Actavis to buy Warner Chilcott in $8.5 bln deal
May 20, 2013 / 11:17 AM / 4 years ago

Actavis to buy Warner Chilcott in $8.5 bln deal

May 20 (Reuters) - Generic drugmaker Actavis Inc will buy specialty pharmaceuticals company Warner Chilcott Plc in a stock deal valued at about $8.5 billion.

Warner Chilcott shareholders will receive 0.160 shares of the combined company, or $20.08 per Warner Chilcott share, based on Actavis’s closing share price of $125.50 on May 17.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below